ATE286402T1 - Verwendung von morinda citrifolia zur behandlung von tinnitus - Google Patents

Verwendung von morinda citrifolia zur behandlung von tinnitus

Info

Publication number
ATE286402T1
ATE286402T1 AT01912627T AT01912627T ATE286402T1 AT E286402 T1 ATE286402 T1 AT E286402T1 AT 01912627 T AT01912627 T AT 01912627T AT 01912627 T AT01912627 T AT 01912627T AT E286402 T1 ATE286402 T1 AT E286402T1
Authority
AT
Austria
Prior art keywords
medicament
extract
morinda citrifolia
leaves
patient
Prior art date
Application number
AT01912627T
Other languages
English (en)
Inventor
Bo Gidlund
Original Assignee
Bo Gidlund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bo Gidlund filed Critical Bo Gidlund
Application granted granted Critical
Publication of ATE286402T1 publication Critical patent/ATE286402T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/746—Morinda
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01912627T 2000-03-02 2001-03-02 Verwendung von morinda citrifolia zur behandlung von tinnitus ATE286402T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0000698A SE516468C2 (sv) 2000-03-02 2000-03-02 Användning av ett extrakt från Morinda citrifolia L. för framställning av läkemedel för behandling av tinnitus.
PCT/SE2001/000447 WO2001064231A1 (en) 2000-03-02 2001-03-02 Use of a composition

Publications (1)

Publication Number Publication Date
ATE286402T1 true ATE286402T1 (de) 2005-01-15

Family

ID=20278673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01912627T ATE286402T1 (de) 2000-03-02 2001-03-02 Verwendung von morinda citrifolia zur behandlung von tinnitus

Country Status (6)

Country Link
EP (1) EP1261358B1 (de)
AT (1) ATE286402T1 (de)
AU (1) AU2001241315A1 (de)
DE (1) DE60108227D1 (de)
SE (1) SE516468C2 (de)
WO (1) WO2001064231A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737089B2 (en) * 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US8652546B2 (en) 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US7244463B2 (en) 2005-10-18 2007-07-17 Tahitian Noni International, Inc. Garcinia mangostana L. enhanced animal food product
US8790727B2 (en) 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US7442395B2 (en) 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
EP4299059A1 (de) 2022-07-01 2024-01-03 Labelic Analysis, S.L. Zusammensetzung zur behandlung von tinnitus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409144A (en) * 1978-01-19 1983-10-11 Research Corporation Of The University Of Hawaii Xeronine, a new alkaloid, useful in medical, food and industrial fields
US5288491A (en) * 1992-09-24 1994-02-22 Herbert Moniz Noni (Morinda Citrifolia) as a pharmaceutical product

Also Published As

Publication number Publication date
DE60108227D1 (de) 2005-02-10
EP1261358B1 (de) 2005-01-05
SE0000698L (de) 2001-09-03
EP1261358A1 (de) 2002-12-04
WO2001064231A1 (en) 2001-09-07
AU2001241315A1 (en) 2001-09-12
SE0000698D0 (sv) 2000-03-02
SE516468C2 (sv) 2002-01-15

Similar Documents

Publication Publication Date Title
Khurshid et al. Green tea (Camellia sinensis): Chemistry and oral health
Nugala et al. Role of green tea as an antioxidant in periodontal disease: The Asian paradox
JP3388117B2 (ja) カイガンショウ抽出物に基づく血小板反応性調節剤の調製方法
ATE299022T1 (de) Verwendung von cyclopamine zur herstellung eines arzneimittels zur behandlung von psoriasis
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
Jia et al. Why bortezomib cannot go with ‘green’?
MXPA02002681A (es) Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer.
SI1778680T1 (sl) Spirociklični cikloheksanski derivati
ATE286402T1 (de) Verwendung von morinda citrifolia zur behandlung von tinnitus
ATE372776T1 (de) Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit
ATE309817T1 (de) Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs
EA200701923A1 (ru) Лекарственная форма для перорального введения витамина
IT1314199B1 (it) Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita'
TW200612903A (en) Use of trisubstituted benzopyranones
ATE410172T1 (de) Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes
KR20010009465A (ko) 금단증상을 억제하는 조성물
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
SE0102887D0 (sv) New formulation
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
DE60008293D1 (de) Pharmazeutische zusammensetzung die einen no donor enthält und dessen therapeutische anwendung
AR047154A1 (es) Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol
DE69936773D1 (de) Behandlung von depression und zusammensetzungen dazu
RU2012156681A (ru) Средство (варианты), фармацевтическая композиция и способ химиопрофилактики предрака и рака предстательной железы
NZ726636A (en) Novel compounds and compositions for targeting cancer stem cells
ATE493976T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties